-
Start Preamble
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Interagency Autism Coordinating Committee (IACC) Subcommittee for Basic and Translational Research.
The IACC Subcommittee for Basic and Translational Research will have a conference call on Wednesday, March 6, 2013. The Subcommittee will discuss future subcommittee activities. The meeting will be accessible by conference call.
Name of Committee: Interagency Autism Coordinating Committee (IACC) Subcommittee for Basic and Translational Research.
Type of meeting: Conference Call.
Date: March 6, 2013.
Time: 2:00 p.m.-5:00 p.m. *Eastern Time*—Approximate end time.
Agenda: The subcommittee will discuss future subcommittee activities.
Place: Conference call only; No in-person meeting.
Conference Call: Dial: 888-316-9409; Access code: 4311740.
Cost: The conference call is free.
Contact Person: Ms. Lina Perez, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, NSC, Room 6182A, Rockville, MD 20852, Phone: (301) 443-6040, Email: IACCPublicInquiries@mail.nih.gov.
Please Note:
The meeting will be open to the public and accessible via conference call. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the conference call, please-email iacchelpdesk2012@gmail.com or call the IACC Technical Support Help Line at 301-339-3840.
Accommodations Statement: Individuals who participate by using the conference call and who need special assistance such as captioning or other reasonable accommodations should submit a request to the Contact Person listed on this notice at least 5 days prior to the meeting.
This meeting notice is being published less than 15 days prior to the meeting due to the urgent need for the subcommittee to discuss subcommittee upcoming activities and emerging issues in the autism community.
Schedule subject to change.
Information about the IACC is available on the Web site: http://www.iacc.hhs.gov.
Start SignatureStart Printed Page 12071End Signature End PreambleDated: February 14, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-03852 Filed 2-20-13; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Effective Date:
- 3/6/2013
- Published:
- 02/21/2013
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2013-03852
- Dates:
- March 6, 2013.
- Pages:
- 12070-12071 (2 pages)
- PDF File:
- 2013-03852.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute